SARS-CoV-2 – COVID-19 Vaccine Research Tools

6 Items

per page
Set Descending Direction
  1. AAV9 (SARS-CoV-2 Spike)
    COV-AV-S
    pAV-CMV-S
    CMV
  2. AAV9 (SARS-CoV-2 Spike, S1 domain)
    COV-AV-S1
    pAV-CMV-S1
    CMV
  3. Adenovirus (SARS-CoV-2 Nucleocapsid)
    COV-AD-N
    pAD-CMV-S-mCMV-copGFP
    CMV
  4. Adenovirus (SARS-CoV-2 Spike)
    COV-AD-S
    pAD-CMV-N-mCMV-copGFP
    CMV
  5. S-Pseudotyped IDLV lentivirus (GFP)
    COV-LENTI-GFP
    Spike protein of SARS-CoV-3
    eGFP
    Yes
  6. S-pseudotyped IDLV Lentivirus (Spike Protein)
    COV-LENTI-S
    Spike protein of SARS-CoV-2
    Spike RNA of SARS-CoV-2
    Yes

6 Items

per page
Set Descending Direction

Covid-19 is caused by the coronavirus, SARS-CoV-2. The Spike protein (S), a structural protein on the surface of the CoV, mediates the interaction between the SARS-CoV-2 and Human cell via ACE2. Nucleocapsid (N) is a structural protein that holds the +RNA viral genome. Both the S protein and N proteins of SARS-CoV-2 are the leading target antigens in COVID-19 vaccine developments. Vigene provides S and N proteins in adenovirus, AAV and pseudotyped lentivirus that could be valuable for COVID-19 research and vaccine developments.